Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    June 2016
  1. MARCELLIN F, Fournier I, Carrieri MP, Poizot-Martin I, et al
    From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).
    Eur J Gastroenterol Hepatol. 2016;28:733-4.
    PubMed     Text format    


    May 2016
  2. YILMAZ B, Unlu O, Evcen R, Ugurluoglu C, et al
    Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient?
    Eur J Gastroenterol Hepatol. 2016;28:607-8.
    PubMed     Text format    


    April 2016
  3. KARAGOZ E, Tanoglu A, Ulcay A, Erdem H, et al
    Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  4. LISON H, Garioud A, Halfon P, Jambon S, et al
    Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV-HCV genotype 1 coinfection.
    Eur J Gastroenterol Hepatol. 2016;28:486-7.
    PubMed     Text format    


    March 2016
  5. GULATI R, Nawaz M, Pyrsopoulos NT
    Comparative analysis of online patient education material pertaining to hepatitis and its complications.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  6. BOTTERO J, Boyd A, Gozlan J, Carrat F, et al
    Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  7. DINTSIOS CM
    Re: Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter? (Eur J Gastroenterol Hepatol 2015, 27:1063-1068).
    Eur J Gastroenterol Hepatol. 2016;28:362.
    PubMed     Text format    


  8. OZARAS R, Tahan V, Tabak F
    More on autoimmune hepatitis and acute hepatitis A.
    Eur J Gastroenterol Hepatol. 2016;28:360.
    PubMed     Text format    


    February 2016
  9. WASZCZUK E, Waszczuk KM, Mulak A, Paradowski L, et al
    Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  10. HELAL GK, Gad MA, Abd-Ellah MF, Mahgoup EM, et al
    Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  11. CARVALHANA SC, Leitao J, Alves AC, Bourbon M, et al
    Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  12. CORSI DJ, Karges W, Thavorn K, Crawley AM, et al
    Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  13. HUNTER JG, Madden RG, Stone AM, Osborne N, et al
    Locally acquired hepatitis E in Cornwall, the UK; geographical clustering, environmental and social factors: a case-controlled study coastal clustering of HEV; Cornwall, UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  14. SELLIER PO, Schnepf N, Amarsy R, Maylin S, et al
    Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  15. OZDEN HT
    Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  16. WANG H, Innes H, Hutchinson SJ, Goldberg DJ, et al
    The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  17. AIZAWA Y, Abe H, Sugita T, Seki N, et al
    Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  18. CHENG XP, Zhao J, Chen Y, Meng FK, et al
    Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  19. SAEZ-ROYUELA F, Linares P, Cervera LA, Almohalla C, et al
    Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  20. ABDEL-RAZIK A, Mousa N, Abdel-Aziz M, Elhelaly R, et al
    Elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  21. LAW ST, Lee MK, Li KK, Mok CK, et al
    Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  22. DETERDING K, Gruner N, Buggisch P, Galle PR, et al
    Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  23. MARTIN DJ, Weideman R, Crook T, Brown G, et al
    Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  24. FEILLANT M, Jezequel C, Lison H, Delluc A, et al
    Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  25. MCEWAN P, Bennett H, Ward T, Webster S, et al
    The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  26. PATRICIO JA JR, Lopes PF, Medeiros T, Mendes GF, et al
    Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  27. KOHLA MA, El-Said H, El-Fert A, Ehsan N, et al
    Impact of nitazoxanide on sustained virologic response in Egyptian patients with chronic hepatitis C genotype 4: a double-blind placebo-controlled trial.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  28. NICOLINI LA, Menzaghi B, Ricci E, Martinelli C, et al
    Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  29. FUJIWARA K, Yasui S, Yokosuka O
    Appropriate diagnostic criteria for fulminant autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015;27:1230-1.
    PubMed     Text format    


  30. BASYIGIT S, Sapmaz F
    Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
    Eur J Gastroenterol Hepatol. 2015;27:1230.
    PubMed     Text format    


  31. KESKIN O, Idilman R
    Sequential development of acute autoimmune hepatitis may lead to a serious clinical picture in primary biliary cirrhosis.
    Eur J Gastroenterol Hepatol. 2015;27:1228-9.
    PubMed     Text format    


    September 2015
  32. EMINLER AT, Ayyildiz T, Irak K, Kyc M, et al
    AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  33. RUDLER M, Thibault V, Mouri S, Akhavan S, et al
    Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  34. HAN SH, Suk KT, Kim DJ, Kim MY, et al
    Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  35. PANG Q, Bi JB, Xu XS, Liu SS, et al
    King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  36. SERRES L, Vasseur P, Tougeron D, Gand E, et al
    Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  37. BELLE A, Baumann C, Bigard MA, Zallot C, et al
    Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Eur J Gastroenterol Hepatol. 2015;27:877-81.
    PubMed     Text format     Abstract available


  38. TRIPPOLI S, Fadda V, Maratea D, Messori A, et al
    Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015;27:983-4.
    PubMed     Text format    


    July 2015
  39. KHEDR MA, E Behairy B, Hussein ME, Marei AM, et al
    Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  40. VERGARA M, Bejarano G, Dalmau B, Gil M, et al
    Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2015;27:826-833.
    PubMed     Text format     Abstract available


    June 2015
  41. ABDEL-GHAFFAR TY, Sira MM, Sira AM, Salem TA, et al
    Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  42. PACOU M, Basso F, Gore C, Hass B, et al
    Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  43. MENDIZABAL M, Marciano S, Videla MG, Anders M, et al
    Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.
    Eur J Gastroenterol Hepatol. 2015;27:644-648.
    PubMed     Text format     Abstract available


    May 2015
  44. OZARAS R, Tahan V, Ozbay G, Ozturk R, et al
    Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  45. CHEN G, Liu H, Hu ZQ, Bai JH, et al
    A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  46. OZEL BD, Poyrazoglu OK, Karaman A, Karaman H, et al
    The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  47. EL-ARABY HA, Ehsan NA, Konsowa HA, Abd-Elaati BM, et al
    Hepatic progenitor cells in children with chronic hepatitis C: correlation with histopathology, viremia, and treatment response.
    Eur J Gastroenterol Hepatol. 2015;27:561-9.
    PubMed     Text format     Abstract available


  48. HALFON P, Penaranda G, Mohamed S, Camus C, et al
    Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practice.
    Eur J Gastroenterol Hepatol. 2015;27:557-60.
    PubMed     Text format     Abstract available


  49. CAUSSE X, Cadranel JF, Potier P, Hanslik B, et al
    Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
    Eur J Gastroenterol Hepatol. 2015;27:544-9.
    PubMed     Text format     Abstract available


  50. ABDELFATTAH MR, Elsiesy H
    Reappraisal of upper age limit for adult living-donor liver transplantation using right lobe grafts: an outcome analysis.
    Eur J Gastroenterol Hepatol. 2015;27:593-9.
    PubMed     Text format     Abstract available


    April 2015
  51. GOVAN L, Wu O, Xin Y, Hutchinson SJ, et al
    Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  52. EFE C, Cengiz M, Kahramanoglu-Aksoy E, Ylmaz B, et al
    Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  53. CUI SB, Shu RH, Yan SP, Wu H, et al
    Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  54. BUYUKASIK NS, Buyukasik Y
    On status of serum iron parameters in chronic hepatitis and cirrhosis: comments on the article by Mao et al.
    Eur J Gastroenterol Hepatol. 2015;27:476.
    PubMed     Text format    


  55. ERCIN CN, Dogru T, Sertoglu E
    Neutrophil-to-lymphocyte ratio as a predictor of fibrosis in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2015;27:475-6.
    PubMed     Text format    


  56. EL-MEZAYEN HA, Habib S, Marzok HF, Saad MH, et al
    Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
    Eur J Gastroenterol Hepatol. 2015;27:378-85.
    PubMed     Text format     Abstract available


  57. SRIVASTAVA A, Mathias A, Yachha SK, Aggarwal R, et al
    Occult hepatitis B infection in children with chronic liver disease.
    Eur J Gastroenterol Hepatol. 2015;27:375-7.
    PubMed     Text format     Abstract available


  58. BELAY T, Woldegiorgis H, Gress T, Rayyan Y, et al
    Intrahepatic cholestasis of pregnancy with concomitant hepatitis C virus infection, Joan C. Edwards SOM, Marshall University.
    Eur J Gastroenterol Hepatol. 2015;27:372-4.
    PubMed     Text format     Abstract available


    March 2015
  59. POH Z, Goh BB, Chang PE, Tan CK, et al
    Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  60. OLIVA-MORENO J, Pena-Longobardo LM, Alonso S, Fernandez-Bolanos A, et al
    Labour productivity losses caused by premature death associated with hepatitis C in Spain.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  61. ZHANG L, Celentano DD, Le Minh N, Latkin CA, et al
    Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  62. IOANNOU GN, Bryson CL, Weiss NS, Boyko EJ, et al
    Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  63. RODRIGUES-PINTO E, Cardoso H, Coelho R, Andrade P, et al
    Higher aspartate aminotransferase platelet ratio index predicts early significant liver-related events in hepatitis C genotype 1 chronic liver disease.
    Eur J Gastroenterol Hepatol. 2015;27:361-2.
    PubMed     Text format    


    February 2015
  64. TAPAN S
    Assessment of the neutrophil to lymphocyte ratio in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2015;27:184-5.
    PubMed     Text format    


  65. KAYADIBI H, Sertoglu E, Uyanik M
    Which diagnostic tool for the prediction of intermediate liver fibrosis stages?
    Eur J Gastroenterol Hepatol. 2015;27:182.
    PubMed     Text format    


    January 2015
  66. YAN S, Wu H, Wang G, Chen Y, et al
    A new model combining the liver/spleen volume ratio and classification of varices predicts HVPG in hepatitis B patients with cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  67. FLISIAK R, Halota W, Tomasiewicz K, Kostrzewska K, et al
    Forecasting the disease burden of chronic hepatitis C virus in Poland.
    Eur J Gastroenterol Hepatol. 2015;27:70-6.
    PubMed     Text format     Abstract available


  68. COBAN M, Sertoglu E
    Should the neutrophil-lymphocyte ratio be used as a noninvasive marker?
    Eur J Gastroenterol Hepatol. 2015;27:108.
    PubMed     Text format    


  69. MORIHARA D, Watanabe H, Takata K, Iwashita H, et al
    Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate.
    Eur J Gastroenterol Hepatol. 2015;27:55-64.
    PubMed     Text format     Abstract available


    December 2014
  70. BESTE LA, Green PK, Ioannou GN
    Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  71. NAKAGAWA A, Atsukawa M, Tsubota A, Shimada N, et al
    Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy.
    Eur J Gastroenterol Hepatol. 2014;26:1329-34.
    PubMed     Text format     Abstract available


    November 2014
  72. MAO W, Hu Y, Lou Y, Chen Y, et al
    Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  73. LI D, Gao G, Jiang H, Tang Z, et al
    Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


    October 2014
  74. BUTI M, Morillas RM, Perez J, Prieto M, et al
    Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  75. KOLLER T, Kollerova J, Huorka M, Meciarova I, et al
    Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2014;26:1108-15.
    PubMed     Text format     Abstract available


  76. GRUNWALD D, Kothari D, Malik R
    Noninvasive markers in the assessment and management of autoimmune liver diseases.
    Eur J Gastroenterol Hepatol. 2014;26:1065-72.
    PubMed     Text format     Abstract available


    September 2014
  77. YLMAZ B, Aydn H, Can G, Senturk Z, et al
    The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  78. KARAGOZ E, Ulcay A, Tanoglu A, Kara M, et al
    Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  79. SERTOGLU E, Kayadibi H, Uyanik M
    Single parameter or index to predict liver injury?
    Eur J Gastroenterol Hepatol. 2014;26:1060.
    PubMed     Text format    


  80. TOPAL E, Catal F, Selimoglu MA, Karabiber H, et al
    Acquired atopic disease after liver transplantation in children; similarities to and differences from adults: a preliminary study.
    Eur J Gastroenterol Hepatol. 2014;26:1055-9.
    PubMed     Text format     Abstract available


    August 2014
  81. YEE BE, Nguyen NH, Zhang B, Vutien P, et al
    Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  82. LV N, Chu XD, Sun YH, Zhao SY, et al
    Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  83. STAHMEYER JT, Rossol S, Bert F, Antoni C, et al
    Cost of treating hepatitis C in Germany: a retrospective multicenter analysis.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


    April 2014
  84. WANG WL, Zhu Y, Cheng JW, Li MX, et al
    Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis.
    Eur J Gastroenterol Hepatol. 2014;26:444-51.
    PubMed     Text format     Abstract available


    February 2014
  85. ERGUL B, Sarikaya M, Dogan Z, Filik L, et al
    Is liver biopsy a problem for patients on chronic hemodialysis?
    Eur J Gastroenterol Hepatol. 2014;26:241-2.
    PubMed     Text format    


    October 2013
  86. ABD ELRAZEK AE , Mahfouz HM, Metwally AM, El-Shamy AM, et al
    Mortality prediction of nonalcoholic patients presenting with upper gastrointestinal bleeding using data mining.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: